Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00512525
Status:
COMPLETED
Last Update Posted:
2009-09-09
First Post:
2007-08-06
Brief Title:
Ghrelin Decreases Insulin Sensitivity
Sponsor:
University of Aarhus
Organization:
University of Aarhus
Study Overview
Official Title:
Intravenous Ghrelin Infusion Decreases Insulin Sensitivity in Healthy Young Men
Status:
COMPLETED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ghrelin administration increases appetite and in rodents induces weight gain The aim of this study is to investigate the effect of short term ghrelin administration to humans on metabolism
Detailed Description:
The current study is initiated in order to assess the impact of acute ghrelin administration on insulin resistance measured by a hyperinsulinemic euglycemic clamp Second as free fatty acid is the predominant substrate during fasting we aim to asses the effects of ghrelin on local and systemic lipolysis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None